New, ongoing, free event series about researchers work in the exciting fields of multi-omics. Each session will take a particular field of omics research and showcase some of the exciting research being undertaken from around the world.
https://european-biotechnology.com/wp-content/uploads/2024/04/csm_pioneers_d9077ee183.jpg479850Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-11-02 07:42:002024-04-02 15:34:58Pioneers of Omics Virtual Event Series
Easier access for central European companies to cryo-EM technique! A modern Thermo Scientific Glacios transmission electron microscope has just been installed at Synchrotron Solaris in Poland and it is open for industrial users.
https://european-biotechnology.com/wp-content/uploads/2024/04/emd_11497.map_xsurface.jpg10491864Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-11-02 07:09:002024-04-02 15:34:59A modern electron microscope (cryo-EM) available for industry at the Solaris Center in Krakow, Poland
https://european-biotechnology.com/wp-content/uploads/2024/04/2021.10.07_EMEA_Whitepaper_Banner_Ads_5_000L-single-use-bioreactors.jpg10801920Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-11-01 13:56:002024-04-02 15:35:00Benefits of 5000 L single-use bioreactors
Eisbach Bio GmbH is a spin-off of the Ludwig Maximilian University in Munich. The company is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried.
Institut Curie spin-off Egle Therapeutics has raised €40m in a Series A financing. The company will use the funds to develop First-In-Class T-regulatory cells therapies based on Treg starvers.
The French company has taken big steps to scale up its process for converting plant-based feedstocks into isobutene, bringing affordable aviation biofuels into reach.
https://european-biotechnology.com/wp-content/uploads/2024/04/contrails-1210064_1920.jpg10161920Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2021-10-21 07:17:002021-10-21 07:17:00From make-up to jet fuel: Breakthrough for Global Bioenergies
Novartis inks US-$1.3bn deal with Dunad Therapeutics
Latest NewsDunad Therapeutics Ltd had entered into a $1.3bn option deal with Swiss pharma major Novartis AG to develop targeted protein degrader therapies.
Pioneers of Omics Virtual Event Series
Sponsored PublicationsNew, ongoing, free event series about researchers work in the exciting fields of multi-omics. Each session will take a particular field of omics research and showcase some of the exciting research being undertaken from around the world.
A modern electron microscope (cryo-EM) available for industry at the Solaris Center in Krakow, Poland
Sponsored PublicationsEasier access for central European companies to cryo-EM technique! A modern Thermo Scientific Glacios transmission electron microscope has just been installed at Synchrotron Solaris in Poland and it is open for industrial users.
AstraZeneca unloads respiratory drugs to Covis
Latest NewsLuxembourg-headquartered Covis is taking two COPD drugs off AstraZeneca’s hands in a US$270m deal.
Benefits of 5000 L single-use bioreactors
Sponsored PublicationsThis white paper focuses on a new generation of single-use bioreactors, built to deliver high-volume performance and how they address many issue.
IZB start-up: Eisbach Bio GmbH
Sponsored PublicationsEisbach Bio GmbH is a spin-off of the Ludwig Maximilian University in Munich. The company is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried.
Agomab Therapeutics to acquire Origo Biopharma
Latest NewsBelgian Agomab Therapeutics NV is expanding its European footprint by acuiring Barcelona-based fibrosis therapy specialist Origo Biopharma.
Evotec goes for massive IPO on Nasdaq
Latest NewsGerman drug discovery company Evotec plans to raise US$576m on the US-American stock exchange Nasdaq to finance extensive investments.
€40m for Treg starver start-up
Latest NewsInstitut Curie spin-off Egle Therapeutics has raised €40m in a Series A financing. The company will use the funds to develop First-In-Class T-regulatory cells therapies based on Treg starvers.
From make-up to jet fuel: Breakthrough for Global Bioenergies
Latest NewsThe French company has taken big steps to scale up its process for converting plant-based feedstocks into isobutene, bringing affordable aviation biofuels into reach.